Suthers Law Firm is currently investigating potential cases involving the drug Actos (pioglitazone), a medication that is prescribed to treat type 2 diabetes. In June of 2011, the U.S. Food & Drug Administration (FDA) issued a warning about the link between Actos and bladder cancer, especially in patients who have taken Actos for more than one year. The FDA warning was based upon a review of data from an ongoing 10 year study, which reported that there may be a 40% increased risk of developing bladder cancer among individuals who take Actos for more than one year. Other countries have taken more aggressive action in limiting the use of Actos. After the release of a French study which showed a possible link between bladder cancer and Actos use, France and Germany suspended the sale and prescription of Actos.
Actos is manufactured by Takeda Pharmaceuticals Company, Ltd. It is co-marketed in the U.S. by Eli Lilly & Company. Lawsuits filed against these manufacturers allege that the manufacturers failed to adequately warn of the increased risk of bladder cancer associated with prolonged Actos use.
If you or someone you know took Actos or pioglitazone and was diagnosed with bladder cancer, contact us online or call us on our toll free number, 1-800-320-2384, to set up a FREE consultation.